These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9607424)

  • 1. Treatment of adults with progressive oligodendroglioma with carboplatin (CBDCA): preliminary results. Writing Committee for The Brain Tumor Center at Duke.
    Friedman HS; Lovell S; Rasheed K; Friedman AH
    Med Pediatr Oncol; 1998 Jul; 31(1):16-8. PubMed ID: 9607424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).
    Poisson M; Péréon Y; Chiras J; Delattre JY
    J Neurooncol; 1991 Apr; 10(2):139-44. PubMed ID: 1654401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of carboplatin in children with progressive low-grade gliomas.
    Gururangan S; Cavazos CM; Ashley D; Herndon JE; Bruggers CS; Moghrabi A; Scarcella DL; Watral M; Tourt-Uhlig S; Reardon D; Friedman HS
    J Clin Oncol; 2002 Jul; 20(13):2951-8. PubMed ID: 12089224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research Hospital.
    Walter AW; Gajjar A; Reardon DA; Thompson SJ; Langston JW; Jones-Wallace D; Kun LE; Heideman RL
    J Pediatr Hematol Oncol; 2000; 22(3):247-51. PubMed ID: 10864056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.
    Friedman HS; Krischer JP; Burger P; Oakes WJ; Hockenberger B; Weiner MD; Falletta JM; Norris D; Ragab AH; Mahoney DH
    J Clin Oncol; 1992 Feb; 10(2):249-56. PubMed ID: 1732426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
    Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
    Wang JL; Barth RF; Cavaliere R; Puduvalli VK; Giglio P; Lonser RR; Elder JB
    PLoS One; 2020; 15(12):e0244383. PubMed ID: 33373402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
    Williams PC; Henner WD; Roman-Goldstein S; Dahlborg SA; Brummett RE; Tableman M; Dana BW; Neuwelt EA
    Neurosurgery; 1995 Jul; 37(1):17-27; discussion 27-8. PubMed ID: 8587686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas.
    Mitchell AE; Elder JE; Mackey DA; Waters KD; Ashley DM
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):572-7. PubMed ID: 11902299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.
    Robins HI; Chang SM; Prados MD; Yung WK; Hess K; Schiff D; Greenberg H; Fink K; Nicolas K; Kuhn JG; Cloughesy T; Junck L; Mehta M
    Neuro Oncol; 2002 Apr; 4(2):109-14. PubMed ID: 11916502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
    Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study.
    Mahoney DH; Cohen ME; Friedman HS; Kepner JL; Gemer L; Langston JW; James HE; Duffner PK; Kun LE
    Neuro Oncol; 2000 Oct; 2(4):213-20. PubMed ID: 11265230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly dosing of carboplatin increases risk of allergy in children.
    Yu DY; Dahl GV; Shames RS; Fisher PG
    J Pediatr Hematol Oncol; 2001; 23(6):349-52. PubMed ID: 11563768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study.
    Aquino VM; Fort DW; Kamen BA
    J Neurooncol; 1999 Feb; 41(3):255-9. PubMed ID: 10359145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.
    Galanis E; Buckner JC; Maurer MJ; Reid JM; Kuffel MJ; Ames MM; Scheithauer BW; Hammack JE; Pipoly G; Kuross SA
    Invest New Drugs; 2005 Oct; 23(5):495-503. PubMed ID: 16133802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.
    Twelves CJ; Ash CM; Miles DW; Thomas DG; Souhami RL
    Cancer Chemother Pharmacol; 1991; 27(6):481-3. PubMed ID: 2013119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience.
    Lafay-Cousin L; Sung L; Carret AS; Hukin J; Wilson B; Johnston DL; Zelcer S; Silva M; Odame I; Mpofu C; Strother D; Bouffet E
    Cancer; 2008 Feb; 112(4):892-9. PubMed ID: 18098210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures.
    Qureshi AI; Suri MF; Khan J; Sharma M; Olson K; Guterman LR; Hopkins LN
    J Neurooncol; 2001 Jan; 51(2):151-8. PubMed ID: 11386412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of temozolomide treatment in patients with high-grade glioma.
    Oshiro S; Tsugu H; Komatsu F; Ohmura T; Ohta M; Sakamoto S; Fukushima T; Inoue T
    Anticancer Res; 2009 Mar; 29(3):911-7. PubMed ID: 19414327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.